Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Neurogene (NGNE) Return on Equity (2018 - 2025)

Neurogene (NGNE) has disclosed Return on Equity for 5 consecutive years, with 0.32% as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Return on Equity rose 8.0% year-over-year to 0.32%, compared with a TTM value of 0.32% through Sep 2025, up 8.0%, and an annual FY2019 reading of 0.66%, changed N/A over the prior year.
  • Return on Equity was 0.32% for Q3 2025 at Neurogene, down from 0.3% in the prior quarter.
  • Across five years, Return on Equity topped out at 0.2% in Q1 2024 and bottomed at 0.4% in Q3 2024.